Disclaimer: This article is intended for educational purposes only and is directed towards licensed researchers. The peptides discussed herein, including vasoactive intestinal peptide (VIP), are intended solely for research and must not be used for in vivo (human or animal) testing. The information provided is based on scientific research and should not be interpreted as medical advice.
Vasoactive Intestinal Peptide (VIP)
Vasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide with significant roles in various physiological processes, including vasodilation, smooth muscle relaxation, and modulation of immune responses. VIP is primarily produced in the gut, pancreas, and hypothalamus, and it acts through specific G-protein-coupled receptors known as VPAC1 and VPAC227.
Biological Functions
VIP plays a crucial role in the regulation of smooth muscle activity, particularly in the respiratory and gastrointestinal systems. It acts as a potent vasodilator, contributing to the regulation of blood flow and blood pressure1. VIP also modulates immune functions by influencing T-cell activity and promoting anti-inflammatory responses4.In the central nervous system (CNS), VIP is involved in neuroprotection and neurodevelopment. It has been implicated in various CNS disorders, including migraines and post-traumatic stress disorder5. Additionally, VIP influences the recruitment of innate lymphoid cells in the gut, enhancing host defense against enteric pathogens7.
Role in Disease
VIP has been associated with several pathological conditions. In cancer biology, VIP and its receptors are involved in tumor growth and differentiation. Studies have shown that VIP can influence the signaling pathways that promote cancer cell proliferation3.Furthermore, VIP-secreting tumors, known as VIPomas, are rare neuroendocrine tumors characterized by excessive secretion of VIP, leading to severe secretory diarrhea and electrolyte imbalances8.
Therapeutic Potential
The therapeutic potential of VIP lies in its ability to modulate immune responses and its involvement in various signaling pathways. Research has focused on developing VIP receptor antagonists as potential treatments for cancer and autoimmune diseases46. In particular, antagonists targeting the VPAC receptors have shown promise in enhancing T-cell activation and improving anti-tumor responses in preclinical models4.
Testing for VIP
Testing for VIP typically involves measuring its levels in biological samples such as blood or tissue extracts. Elevated levels of VIP can be indicative of certain pathological conditions, such as VIPomas.
Diagnostic Methods
- Immunoassays: Enzyme-linked immunosorbent assays (ELISA) are commonly used to quantify VIP levels in plasma or serum samples. These assays rely on specific antibodies that bind to VIP, allowing for its detection and quantification.
- Mass Spectrometry: Advanced techniques like mass spectrometry can provide detailed information about the peptide’s structure and concentration in biological samples. This method offers high sensitivity and specificity.
- Molecular Imaging: Techniques such as positron emission tomography (PET) can be used to visualize VIP receptor expression in vivo, aiding in the diagnosis of tumors expressing these receptors.
Research Applications
In research settings, testing for VIP often involves studying its interactions with receptors or other molecules. Techniques such as molecular docking simulations help elucidate the binding mechanisms of VIP with its receptors or inhibitors3. In vitro studies using cell lines can further explore the effects of VIP on cellular signaling pathways2.
Benefits and Contraindications
Benefits
Research has demonstrated several potential benefits of VIP:
- Anti-inflammatory Effects: VIP has been shown to reduce inflammation by modulating cytokine production and inhibiting pro-inflammatory pathways5.
- Neuroprotective Properties: In CNS disorders, VIP may offer neuroprotective effects by supporting neuronal survival and reducing oxidative stress5.
- Cancer Therapy: The modulation of immune responses by VIP antagonists presents a promising approach for cancer immunotherapy4.
Contraindications and Side Effects
While research indicates potential therapeutic benefits, there are also considerations regarding contraindications:
- Tumor Promotion: In some cancers, elevated levels of VIP may promote tumor growth, necessitating caution when considering therapeutic applications involving VIP3.
- Immune Suppression: As an immunomodulatory peptide, inappropriate use of VIP could potentially suppress immune functions, leading to increased susceptibility to infections4.
Conclusion
Vasoactive intestinal peptide (VIP) is a multifunctional neuropeptide with significant roles in physiological regulation and disease pathology. Its involvement in immune modulation, smooth muscle relaxation, and CNS function highlights its therapeutic potential across various medical fields. However, further research is necessary to fully understand its mechanisms of action and to develop safe therapeutic applications.
References
- 1 Neonatal hyperoxia increases contraction and decreases the relaxation of airway smooth muscle (ASM). Retrieved from https://www.semanticscholar.org/paper/d4ea9b4afd5ef2bb910f4b4cf15bc89fd3680bca
- 2 Recent advances of vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating polypeptide (PACAP) receptors. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33449573/
- 3 Heparin oligosaccharides as vasoactive intestinal peptide inhibitors via their binding process characterization. Retrieved from https://pubmed.ncbi.nlm.nih.gov/38284716/
- 4 Inhibition of vasoactive intestinal peptide signaling augments T-cell activation. Retrieved from https://www.semanticscholar.org/paper/7fbc26dedea4fad5b61b63be6e7d7aacbea79174
- 5 Biology and clinical importance of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide (VIP/PACAP). Retrieved from https://pubmed.ncbi.nlm.nih.gov/33481421/
- 6 Optimization of ex vivo activation and expansion of T cells via antagonism of PI3K δ and vasoactive intestinal peptide signaling. Retrieved from https://www.semanticscholar.org/paper/867eea9b52793fde5f372d7baf4a4c5f706b53fd
- 7 Vasoactive intestinal peptide promotes host defense against enteric pathogens by modulating group 3 innate lymphoid cells recruitment. Retrieved from https://pubmed.ncbi.nlm.nih.gov/34625492/
- 8 Diagnostic challenges in vasoactive intestinal peptide secreting tumors: A series of 15 patients. Retrieved from https://pubmed.ncbi.nlm.nih.gov/31268974/